Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health announced that starting February 11, it will administer COVID-19 vaccines at 18 locations in Maryland. This initiative is part of a broader rollout across 11 states, with an initial supply of approximately 11,000 doses. Appointments can be booked from February 9, and only eligible individuals who meet state criteria can receive vaccinations. CVS aims to expand its services as more vaccines become available, with a capacity to administer 20-25 million shots monthly. The company also continues vaccination efforts in over 1,700 long-term care facilities.
CVS Health will begin administering COVID-19 vaccines at 100 locations across California starting February 11, 2021. Approximately 81,900 doses will be available initially, with appointments open for booking on February 9. This effort is part of a broader rollout in 11 states, expanding CVS's capacity to deliver 20-25 million vaccinations monthly. The company also continues to vaccinate residents at over 15,000 long-term care facilities in California. CVS aims to make healthcare more accessible and affordable while addressing the ongoing pandemic.
CVS Health will start administering COVID-19 vaccines to eligible residents on February 11 at 12 pharmacy locations in Connecticut. The rollout will include approximately 6,800 doses sourced from a federal partnership program. Appointments can be booked from February 9. The initiative is part of a broader plan involving 335 locations across 11 states with a capacity to administer 20-25 million shots monthly. CVS is also vaccinating residents at over 570 long-term care facilities in Connecticut, aiming to finish first doses by mid-February.
CVS Health will start offering COVID-19 vaccinations on February 11 at select locations across 11 states, initially providing approximately 250,000 doses sourced from the federal government. The company plans to expand its vaccination efforts as more supply becomes available. CVS aims to administer 20 to 25 million shots monthly, utilizing nearly 90,000 healthcare professionals. CVS has already begun vaccinations at long-term care facilities, aiming to complete first doses for over 40,000 facilities by mid-February.
CVS Health Corporation (NYSE:CVS) will host a conference call on February 16, 2021, at 8:00 a.m. ET to discuss its financial results for the fourth quarter of 2020. The call will be available via live audio webcast on CVS Health's Investor Relations website. The event aims to inform analysts and investors about the company's performance and strategic initiatives. CVS Health continues to enhance healthcare access and affordability through innovative services and community outreach that cater to the healthcare needs of nearly one in three Americans annually.
CVS Health Foundation has launched a $5 million Health Care Careers Scholarship program over five years, aimed at supporting Black and Latinx students pursuing health care degrees. This initiative is part of CVS's broader $600 million commitment to address racial inequities. Scholarships will target students in various health care-related fields and will be managed in collaboration with UNCF. Applications are open from February 1 to April 1, 2021, fostering a diverse pipeline of future health care professionals.
CVS Health has successfully administered the first round of COVID-19 vaccine doses to nearly 8,000 skilled nursing facilities across the U.S. With second doses already underway, CVS anticipates completion within four weeks. The rollout included more than 40,000 long-term care facilities, with first doses expected to be finished by mid-February. CVS can administer 20-25 million vaccine shots monthly, significantly impacting community vaccination efforts in partnership with federal programs.
CVS Health announces the appointment of Laurie Havanec as Executive Vice President and Chief People Officer, effective February 8, 2021. She succeeds Lisa Bisaccia, who is retiring after 16 years. Havanec brings over 20 years of HR experience, most recently from Otis Worldwide Co., and has previously held significant roles at United Technologies Corporation and Aetna. Havanec aims to enhance talent and culture initiatives, supporting CVS's strategy with a focus on engaging its workforce of 300,000 employees.
CVS Health (NYSE: CVS) has appointed Michelle Peluso as its first-ever Chief Customer Officer, effective January 25, 2021. This new executive role will focus on transforming the consumer experience and enhancing CVS's digital strategy. Peluso, who has over 25 years of experience, previously held senior positions at IBM and Citigroup, managing substantial revenue and improving customer engagement. Her addition aims to provide a personalized and seamless experience for customers within CVS Health's diverse healthcare offerings.
CVS Health is administering COVID-19 vaccines in skilled nursing facilities across 49 states, starting in 36 states and Washington, D.C. The first doses are expected to be completed by January 25. Approximately 8,000 out of 15,000 skilled nursing facilities have partnered with CVS. While the uptake among residents is high, initial staff vaccination rates are low, attributed to staggered visits. CVS plans to expand vaccine availability at retail locations based on state decisions. The company can administer 20-25 million shots per month.